Business & Regulatory Report
Monthly pharma and biotech industry news
Business & Regulatory Report is the monthly business supplement to The Cancer Letter. This 8-page digest provides a succinct overview of industry news relevant to cancer therapeutics development, clinical care, and oncology practice management. It provides a simple way of following news about clinical trials, industry deals and collaborations, FDA approvals and submissions, patents, and oncology management. It comes with a subscription to The Cancer Letter.